EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

sFRP5 ameliorates atherosclerosis by suppressing the JNK/TLR9 pathway in macrophages

Yue Yu, Han Chen, Rui Wang, Fei Xu, Jiasheng Yin, Tongtong Zang, Changyi Zhou, Chengpeng Liu, Chaofu Li, Li Shen, Junbo Ge

Translational Research · 2025

DOI: 10.1016/j.trsl.2025.05.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Research, 2025. Verfasst von Yue Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, PR China. Hauptthemen laut MEDLINE: Atherosclerosis, Macrophages, Toll-Like Receptor 9, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Secreted frizzled related protein 5 (sFRP5), an anti-inflammatory adipokine, plays a crucial role in various diseases, and its serum levels are low in patients with coronary artery disease (CAD). However, its role in atherosclerosis remains unclear. Therefore, we investigated the correlation between sFRP5 and plaque stability, along with the molecular mechanisms underlying atherosclerosis. In patients with CAD, serum sFRP5 levels were positively correlated with plaque stability, a predictor of thin-cap fibroatheromas (TCFAs). Recombinant sFRP5 (r-sFRP5) supplementation significantly increased plaque stability and ameliorated atherosclerosis progression in ApoE-/- mice. Aortic RNA-sequencing (RNA-seq) revealed sFRP5-mediated regulation in inflammatory cells. Our experiments confirmed that sFRP5 inhibits inflammation and macrophage migration. Mechanistically, Toll-like receptor 9 (TLR9) was identified as a downstream target of sFRP5, and sFRP5 suppressed TLR9 expression by decreasing c-Jun N-terminal kinase (JNK) phosphorylation. These findings suggest that serum sFRP5 levels are associated with plaque stability and play a protective role in atherosclerosis by attenuating inflammation and macrophage infiltration via inhibition of the JNK/TLR9 pathway, thereby ameliorating the progression of atherosclerosis. This study highlights the potential of sFRP5 as both a biomarker and therapeutic target for plaque stability in atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisMacrophagesToll-Like Receptor 9Adaptor Proteins, Signal TransducingMAP Kinase Signaling SystemJNK Mitogen-Activated Protein KinasesMembrane ProteinsAnimalsMiceHumansMaleMice, Inbred C57BLFemaleSignal TransductionPlaque, AtheroscleroticSecreted Frizzled-Related Proteins

Stichwörter der Autor:innen

AtherosclerosisInflammationMacrophageSecreted frizzled related protein 5Thin-cap fibroatheromas

Substanzen

Toll-Like Receptor 9Adaptor Proteins, Signal TransducingJNK Mitogen-Activated Protein KinasesMembrane ProteinsSFRP5 protein, humanSecreted Frizzled-Related ProteinsSfrp5 protein, mouseTlr9 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, PR China.
  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, PR China. Electronic address: shen.li1@zs-hospital.sh.cn.
  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, PR China. Electronic address: jbge@zs-hospital.sh.cn.

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Chinese Academy of Medical Sciences
  • Fudan University

Zitieren

APA

Yu, Y., Chen, H., Wang, R., Xu, F., Yin, J., Zang, T., Zhou, C., Liu, C., Li, C., Shen, L., & Ge, J. (2025). sFRP5 ameliorates atherosclerosis by suppressing the JNK/TLR9 pathway in macrophages. Translational Research. https://doi.org/10.1016/j.trsl.2025.05.004

Vancouver

Yu Y, Chen H, Wang R, Xu F, Yin J, Zang T, et al. sFRP5 ameliorates atherosclerosis by suppressing the JNK/TLR9 pathway in macrophages. Translational Research. 2025. doi:10.1016/j.trsl.2025.05.004

BibTeX
@article{Yu2025,
  author = {Yu, Yue and Chen, Han and Wang, Rui and Xu, Fei and Yin, Jiasheng and Zang, Tongtong and Zhou, Changyi and Liu, Chengpeng and Li, Chaofu and Shen, Li and Ge, Junbo},
  title = {sFRP5 ameliorates atherosclerosis by suppressing the JNK/TLR9 pathway in macrophages},
  journal = {Translational Research},
  year = {2025},
  doi = {10.1016/j.trsl.2025.05.004}
}
Kostenlos starten →